Metuchen Pharmaceuticals
Manalapan, US · Founded 2016 · Delaware LLC
Founders & leadership
KL
Keith LavanNamed on SEC filing
JD
John D. ShulmanNamed on SEC filing
GF
Greg FordNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3.1M disclosed across 1 round · 2019
▶$3.1MraisedJan 2020 · 30 investors · PharmaceuticalsRule 506(b)
▶$3.1MraisedJan 2020 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Keith LavanExecutive Officer
- John D. ShulmanExecutive Officer, Director
- Greg FordExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $3.1M
- First sale
- Sep 2019
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Metuchen Pharmaceuticals raised?
- Metuchen Pharmaceuticals has disclosed $3.1M raised across 1 round.
- Where is Metuchen Pharmaceuticals headquartered?
- Metuchen Pharmaceuticals is headquartered in Manalapan, US.